Gradalis Revenue and Competitors
Estimated Revenue & Valuation
- Gradalis's estimated annual revenue is currently $2.7M per year.
- Gradalis's estimated revenue per employee is $77,500
- Gradalis's total funding is $67.9M.
Employee Data
- Gradalis has 35 Employees.
- Gradalis grew their employee count by -42% last year.
Gradalis's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO & Chairman the Board | Reveal Email/Phone |
2 | Controller | Reveal Email/Phone |
3 | VP, Clinical and Regulatory Operations | Reveal Email/Phone |
4 | General Counsel | Reveal Email/Phone |
5 | VP, Medical and Scientific Affairs | Reveal Email/Phone |
6 | Chief Operating Officer | Reveal Email/Phone |
7 | Chief Scientific Officer | Reveal Email/Phone |
8 | Director - Scientific Liaison | Reveal Email/Phone |
9 | Chief Financial Officer | Reveal Email/Phone |
10 | Senior Director Site Research | Reveal Email/Phone |
Gradalis Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.7M | 11 | -8% | N/A | N/A |
#2 | $14.9M | 96 | -6% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 10 | 0% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 48 | -2% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $1.6M | 10 | 0% | N/A | N/A |
#10 | $16.3M | 105 | 62% | N/A | N/A |
What Is Gradalis?
We are a late-stage biopharmaceutical company focused on the development and commercialization of novel personalized therapeutics to treat cancer. We are developing Vigil®, our proprietary immunotherapy platform in multiple advanced cancer indications.
keywords:N/A
$67.9M
Total Funding
35
Number of Employees
$2.7M
Revenue (est)
-42%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Gradalis News
Achilles Therapeutics plc; Advaxis, Inc.; Frame Cancer Therapeutics; Genocea, Gradalis, Inc.; Gritstone Oncology; Immunicum AB; Medigene AG;...
... To Grow During the Forecast Period (2019-2032), DelveInsight | Key Companies- Gradalis, Eisai, Salarius Pharmaceuticals, and Others.
... Novocure, Gradalis, Karyopharm Therapeutics, Bayer, EMD Merck, Macrogenics, Sorrento Therapeutics, US Oncology, Myriad Pharmaceuticals.
Gradalis, a Dallas, Texas-basedbiotechnology company, has raised $24m in Series B financing. Backers were not disclosed. Led by David Shanahan, president, CEO and co-founder, Gradalis focuses on developing, manufacturing and commercializing drugs, vaccines, tools and diagnostics primarily in t ...
Other Companies in Carrollton
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.1M | 35 | 6% | N/A |
#2 | $7.1M | 35 | 9% | N/A |
#3 | $3.5M | 35 | 0% | N/A |
#4 | $9.2M | 35 | -22% | N/A |
#5 | $8.1M | 35 | 9% | N/A |